Saniona AB (publ) (SANION.ST)
SEK 8.05
(3.34%)
SEK 8.05
(3.34%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.78 Million SEK | -824.18% |
| 2022 | 10.8 Million SEK | 84.82% |
| 2021 | 5.84 Million SEK | 18.24% |
| 2020 | 4.94 Million SEK | 675.79% |
| 2019 | -859 Thousand SEK | -101.69% |
| 2018 | 50.79 Million SEK | 191.44% |
| 2017 | 17.42 Million SEK | -76.27% |
| 2016 | 73.44 Million SEK | 534.24% |
| 2015 | 11.58 Million SEK | -42.07% |
| 2014 | 19.98 Million SEK | 54.18% |
| 2013 | 12.96 Million SEK | 93.21% |
| 2012 | 6.71 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -10.75 Million SEK | 41.7% |
| 2024 Q2 | -7.16 Million SEK | 162.89% |
| 2023 Q3 | 3.91 Million SEK | 43.99% |
| 2023 Q2 | 2.71 Million SEK | 140.83% |
| 2023 Q4 | -18.45 Million SEK | -571.29% |
| 2023 FY | -78.26 Million SEK | -824.18% |
| 2023 Q1 | 1.12 Million SEK | -50.13% |
| 2022 Q2 | 2.02 Million SEK | -60.33% |
| 2022 FY | 10.8 Million SEK | 84.82% |
| 2022 Q1 | 5.1 Million SEK | 218.15% |
| 2022 Q4 | 2.26 Million SEK | 59.32% |
| 2022 Q3 | 1.42 Million SEK | -29.76% |
| 2021 FY | 5.84 Million SEK | 18.24% |
| 2021 Q1 | 2.69 Million SEK | 11.55% |
| 2021 Q4 | 1.6 Million SEK | 109.0% |
| 2021 Q3 | 767 Thousand SEK | -2.04% |
| 2021 Q2 | 783 Thousand SEK | -70.95% |
| 2020 FY | 4.94 Million SEK | 675.79% |
| 2020 Q4 | 2.41 Million SEK | 47.41% |
| 2020 Q1 | -261 Thousand SEK | -107.18% |
| 2020 Q2 | 1.15 Million SEK | 541.0% |
| 2020 Q3 | 1.63 Million SEK | 42.4% |
| 2019 Q2 | -143 Thousand SEK | -119.4% |
| 2019 Q4 | 3.63 Million SEK | 770.3% |
| 2019 Q3 | -542 Thousand SEK | -279.02% |
| 2019 FY | -859 Thousand SEK | -101.69% |
| 2019 Q1 | 737 Thousand SEK | -42.91% |
| 2018 Q4 | 1.29 Million SEK | -97.02% |
| 2018 Q2 | 2.7 Million SEK | -22.88% |
| 2018 Q1 | 3.51 Million SEK | -1.07% |
| 2018 Q3 | 43.28 Million SEK | 1499.08% |
| 2018 FY | 50.79 Million SEK | 191.44% |
| 2017 Q2 | 3.31 Million SEK | -51.09% |
| 2017 Q4 | 3.54 Million SEK | -6.56% |
| 2017 Q1 | 6.77 Million SEK | 41.67% |
| 2017 Q3 | 3.79 Million SEK | 14.64% |
| 2017 FY | 17.42 Million SEK | -76.27% |
| 2016 Q2 | 3.16 Million SEK | -79.37% |
| 2016 Q1 | 15.35 Million SEK | 942.36% |
| 2016 FY | 73.44 Million SEK | 534.24% |
| 2016 Q4 | 4.78 Million SEK | -90.47% |
| 2016 Q3 | 50.14 Million SEK | 1483.33% |
| 2015 Q3 | 1.59 Million SEK | -62.77% |
| 2015 Q4 | 1.47 Million SEK | -7.82% |
| 2015 FY | 11.58 Million SEK | -42.07% |
| 2015 Q1 | 4.21 Million SEK | 34.09% |
| 2015 Q2 | 4.29 Million SEK | 1.78% |
| 2014 Q3 | 5.09 Million SEK | -5.05% |
| 2014 FY | 19.98 Million SEK | 54.18% |
| 2014 Q4 | 3.14 Million SEK | -38.28% |
| 2014 Q1 | 2.94 Million SEK | 0.0% |
| 2014 Q2 | 5.36 Million SEK | 82.18% |
| 2013 FY | 12.96 Million SEK | 93.21% |
| 2012 FY | 6.71 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | -160.68 Million SEK | 107.332% |
| Ziccum AB (publ) | -23.28 Million SEK | 150.593% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| BioArctic AB (publ) | 346.31 Million SEK | 96.598% |
| Sprint Bioscience AB (publ) | 41.78 Million SEK | 71.807% |
| Mendus AB (publ) | 28.48 Million SEK | 58.644% |
| Genovis AB (publ.) | 54 Million SEK | 78.184% |
| Intervacc AB (publ) | -13.79 Million SEK | 185.407% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | 2.17 Million SEK | -442.653% |
| Active Biotech AB (publ) | -1.67 Million SEK | 803.343% |
| Magle Chemoswed Holding AB (publ) | 9.96 Million SEK | -18.248% |
| Bio-Works Technologies AB (publ) | 26.82 Million SEK | 56.075% |
| Aptahem AB (publ) | 2.63 Million SEK | -347.836% |
| Vicore Pharma Holding AB (publ) | -3.42 Million SEK | 444.373% |
| Kancera AB (publ) | -1.96 Million SEK | 699.542% |
| Infant Bacterial Therapeutics AB (publ) | 77 Thousand SEK | -15200.0% |
| Fluicell AB (publ) | 1.73 Million SEK | -577.848% |
| Lipigon Pharmaceuticals AB (publ) | -5.11 Million SEK | 330.233% |
| Biovica International AB (publ) | 6.87 Million SEK | -71.31% |
| Spago Nanomedical AB (publ) | -23.28 Million SEK | 150.599% |
| AcouSort AB (publ) | 8.38 Million SEK | -40.434% |
| Xintela AB (publ) | 78 Thousand SEK | -15003.846% |
| Abliva AB (publ) | -35.66 Million SEK | 133.034% |
| Egetis Therapeutics AB (publ) | -146.9 Million SEK | 108.02% |
| Karolinska Development AB (publ) | 2.8 Million SEK | -319.701% |
| OncoZenge AB (publ) | 3000.00 SEK | -392600.0% |
| Amniotics AB (publ) | -1.93 Million SEK | 710.415% |
| 2cureX AB (publ) | -37.48 Million SEK | 131.427% |
| CombiGene AB (publ) | -21.29 Million SEK | 155.334% |
| Asarina Pharma AB (publ) | -423 Thousand SEK | 2885.106% |
| Calliditas Therapeutics AB (publ) | 1.12 Billion SEK | 98.957% |
| Camurus AB (publ) | 1.58 Billion SEK | 99.255% |
| Corline Biomedical AB | 28.38 Million SEK | 58.488% |
| IRLAB Therapeutics AB (publ) | -122.73 Million SEK | 109.599% |
| Isofol Medical AB (publ) | -34.41 Million SEK | 134.232% |
| I-Tech AB | 27.56 Million SEK | 57.263% |
| Hansa Biopharma AB (publ) | 70.95 Million SEK | 83.396% |
| Cyxone AB (publ) | 2.61 Million SEK | -351.206% |
| ExpreS2ion Biotech Holding AB (publ) | 3.4 Million SEK | -246.195% |
| Biosergen AB | -456 Thousand SEK | 2683.553% |
| Cantargia AB (publ) | -3.45 Million SEK | 441.379% |
| NextCell Pharma AB | -43.74 Million SEK | 126.929% |
| Xspray Pharma AB (publ) | -9.19 Million SEK | 228.138% |
| Elicera Therapeutics AB (publ) | 11.21 Million SEK | -5.016% |
| Nanologica AB (publ) | -76 Thousand SEK | 15601.316% |
| SynAct Pharma AB | -778 Thousand SEK | 1614.267% |
| Annexin Pharmaceuticals AB (publ) | -193 Thousand SEK | 6204.145% |
| Stayble Therapeutics AB (publ) | - SEK | -Infinity% |
| LIDDS AB (publ) | -12.92 Million SEK | 191.17% |
| Lipum AB (publ) | 53 Thousand SEK | -22128.302% |
| BioInvent International AB (publ) | 71.46 Million SEK | 83.514% |
| Alzinova AB (publ) | 19.87 Million SEK | 40.722% |
| Oncopeptides AB (publ) | 36.29 Million SEK | 67.545% |
| Pila Pharma AB (publ) | 1.46 Million SEK | -705.252% |
| Guard Therapeutics International AB (publ) | -15 Thousand SEK | 78640.0% |
| Scandinavian ChemoTech AB (publ) | 1.65 Million SEK | -610.555% |
| Simris Alg AB (publ) | 2 Million SEK | -486.996% |
| Diamyd Medical AB (publ) | -3.58 Million SEK | 429.078% |
| Xbrane Biopharma AB (publ) | 35.38 Million SEK | 66.709% |
| Ascelia Pharma AB (publ) | -1.04 Million SEK | 1223.07% |
| Diagonal Bio AB (publ) | 3.13 Million SEK | -276.029% |